AUTOMATION specialist MPS
has announced a partnership with
Guildlink which help pharmacies
identify DAA opportunities,
automate their DAA business and
“provide other services to improve
efficiencies in store”.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 15 Mar 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Mar 16
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).